Table 1.
Demographic data and distribution of all study participants
| Variable | All patients | Three groups | ||
|---|---|---|---|---|
| n = 127 | DMN (n = 26) 26/127 (20.5%) | DPN (n = 92) 92/127 (72.4%) | NDN (n = 9) 9/127 (7.1%) | |
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | |
| Age (years) | 58.4 ± 9.8 | 58.4 ± 9.5 | 59.4 ± 9.3 | 52.9 ± 6.5 |
| Sex (female/male) | 57/68 | 15/11 | 36/56 | 7/2 |
| Duration (months) | 113.1 ± 80.2 | 112.4 ± 78 | 115.1 ± 83.7 | 88.7 ± 85.4 |
| NGSP HbA1c (%) | 7.7 ± 1.2 | 7.3 ± 1.2 | 7.8 ± 1.3 | 7.5 ± 1.0 |
| IFCC HbA1c (mmol/mol) | 60.4 ± 13.7 | 56.3 ± 13.6 | 61.9 ± 13.8 | 59.1 ± 11.4 |
DMN, diabetic mononeuropathy; DPN, diabetic polyneuropathy; HbA1c, hemoglobin A1c; IFCC, International Federation of Clinical Chemistry; NDN, non‐neuropathy; NGSP, National Glycohemoglobin Standardization Program.